Lyrinel XL use in children

The licence for Lyrinel XL (oxybutynin prolonged release) has been extended to include use in children over six years. Previously, use in children under 18 years was not recommended.

The recommended starting dose for children over six years is 5mg once daily, increasing by 5mg increments up to a maximum of 15mg once daily. The safety and efficacy of Lyrinel XL has not been established in patients under six years.

Further information: Janssen-Cilag Ltd 01494 567444

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Contraceptive shortages reported by manufacturers

Contraceptive shortages reported by manufacturers

Shortages of several contraceptives, including combined,...

Hormone Replacement Therapy (HRT)

Hormone Replacement Therapy (HRT)

Hormone doses and costs of HRT preparations.

Drug shortages - live tracker

Drug shortages - live tracker

Added: FemSeven Sequi and FemSeven Conti.
Use...

Last chance to register for the next Respiratory and Allergy Learning Series event

Last chance to register for the next Respiratory and Allergy Learning Series event

Join Dr Steve Holmes, who will be chairing the MIMS...